Citation Impact
Citing Papers
WGCNA: an R package for weighted correlation network analysis
2008 Standout
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
2011
PapA3 Is an Acyltransferase Required for Polyacyltrehalose Biosynthesis in Mycobacterium tuberculosis
2009 StandoutNobel
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
1998
Activators of the nuclear receptor PPARγ enhance colon polyp formation
1998
Tumor Necrosis Factor-α Causes Insulin Receptor Substrate-2-Mediated Insulin Resistance and Inhibits Insulin-Induced Adipogenesis in Fetal Brown Adipocytes1
1998
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Inflammation and metabolic disorders
2006 StandoutNature
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 Standout
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 StandoutNature
Mycobacterium tuberculosis Invasion of Macrophages: Linking Bacterial Gene Expression to Environmental Cues
2007
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
1997
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
1997
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
1997
The metabolic syndrome
2010 Standout
Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor
1998
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1
1999 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes Mellitus
1999
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
1997 StandoutNature
Interaction of Tumor Necrosis Factor-α- and Thiazolidinedione-Regulated Pathways in Obesity
2004
Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice
1997 Standout
Inflammation, stress, and diabetes
2005 Standout
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
1997 Standout
Glucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
1999
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
1998 Standout
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice
1996
Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists
1998
Genetic and Genomic Analysis of a Fat Mass Trait with Complex Inheritance Reveals Marked Sex Specificity
2006
The metabolic syndrome
2005 Standout
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
1998
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2000
Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB
2003
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Eye Development and Retinogenesis
2012
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Integrating Genetic and Network Analysis to Characterize Genes Related to Mouse Weight
2006
Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene
1997
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
2001
Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E
1998 StandoutNobel
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Fatty Acid Binding Proteins—The Evolutionary Crossroads of Inflammatory and Metabolic Responses
2004
In VivoEffects of Pioglitazone on Uncoupling Protein-2 and -3 mRNA Levels in Skeletal Muscle of Hyperglycemic KK Mice
1998
Adipogenesis and Obesity: Rounding Out the Big Picture
1996
Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists
2005
Regulation of Gene Expression by Activation of the Peroxisome Proliferator-Activated Receptor γ with Rosiglitazone (BRL 49653) in Human Adipocytes
1999
Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
2001
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Identification of Wortmannin-sensitive Targets in 3T3-L1 Adipocytes
1999
Peroxisome proliferator-activated receptor agonists
1997
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
2004 StandoutNature
The hormone resistin links obesity to diabetes
2001 StandoutNature
Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
1996
What We Talk About When We Talk About Fat
2014 Standout
Using genetic markers to orient the edges in quantitative trait networks: The NEO software
2008
Interdomain communication regulating ligand binding by PPAR-γ
1998 Nature
Leptin and the regulation of body weight in mammals
1998 StandoutNature
The RXR heterodimers and orphan receptors
1995 Standout
Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass
2003
Atherosclerosis
2001 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Roles of PPARs in health and disease
2000 StandoutNature
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
A role for preadipocytes as macrophage‐like cells
1999
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing’s Syndrome
2005
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
The Mechanisms of Action of PPARs
2002 Standout
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes
2002
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator
2003
Inferring Causal Phenotype Networks From Segregating Populations
2008
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
1999 StandoutScience
Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism
1999
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo
2000
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPARγ Agonist) Action
1998
Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression
1998
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Identification of a Nuclear Receptor for Bile Acids
1999 StandoutScience
Role of Peroxisome Proliferator-Activated Receptor-γ in Maintenance of the Characteristics of Mature 3T3-L1 Adipocytes
2002
Nuclear Receptors Have Distinct Affinities for Coactivators: Characterization by Fluorescence Resonance Energy Transfer
1998
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of N. Berger being referenced
An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues.
1996
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
1996
Gene Expression Profile in Neisseria meningitidis and Neisseria lactamica upon Host‐Cell Contact
2002
Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation
2003
RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice
2010
PI 3-Kinase Activation Is Required for Insulin Stimulation of Glucose Transport into L6 Myotubes
1994
An integrative genomics approach to the reconstruction of gene networks in segregating populations
2004
An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues
1996
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice
1996
On the role of Müller glia cells in histogenesis: only retinal spheroids, but not tectal, telencephalic and cerebellar spheroids develop histotypical patterns.
1997
Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
1995